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Abstract
The development of a biofilm constitutes a survival strategy by providing bacteria a protective environment safe from
stresses such as microbicide action and can thus lead to important health-care problems. In this study, biofilm resistance of
a Bacillus subtilis strain (called hereafter NDmedical) recently isolated from endoscope washer-disinfectors to peracetic acid
was investigated and its ability to protect the pathogen Staphylococcus aureus in mixed biofilms was evaluated. Biocide
action within Bacillus subtilis biofilms was visualised in real time using a non-invasive 4D confocal imaging method. The
resistance of single species and mixed biofilms to peracetic acid was quantified using standard plate counting methods and
their architecture was explored using confocal imaging and electronic microscopy. The results showed that the NDmedical
strain demonstrates the ability to make very large amount of biofilm together with hyper-resistance to the concentration of
PAA used in many formulations (3500 ppm). Evidences strongly suggest that the enhanced resistance of the NDmedical strain
was related to the specific three-dimensional structure of the biofilm and the large amount of the extracellular matrix
produced which can hinder the penetration of peracetic acid. When grown in mixed biofilm with Staphylococcus aureus, the
NDmedical strain demonstrated the ability to protect the pathogen from PAA action, thus enabling its persistence in the
environment. This work points out the ability of bacteria to adapt to an extremely hostile environment, and the necessity of
considering multi-organism ecosystems instead of single species model to decipher the mechanisms of biofilm resistance to
antimicrobials agents.
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Introduction
In response to environmental conditions, bacteria have de-
veloped different strategies to adapt and survive. The formation of
multicellular communities known as biofilms is one such strategy,
which is associated with increased bacterial resistance to environ-
mental stress accompanying antimicrobial treatments [1,2]. It has
indeed been shown that non-lethal concentrations of antibiotics or
disinfectants can stimulate biofilm formation [3,4] which consti-
tutes a defensive response to the toxic effects of the biocides.
Mechanisms involved in the resistance of biofilms remain unclear
but appear to result from multifactorial processes related to the
architecture of the edifice and the phenotypic features of the cells.
The presence of a protective extracellular matrix via the
expression of specific genes in the biofilm, the metabolic state of
cells due to microenvironmental conditions have all been identified
as playing a role in biofilm resistance to antimicrobial agents [5].
In the clinical settings, biofilms promote infection through, for
example, the persistence of bacteria on medical devices and thus
can act as reservoir for pathogens [6,7]. It has been estimated that
65% of nosocomial infections directly involve biofilms [8]. Of all
medical devices used, flexible endoscopes are among the most
frequently associated with outbreaks of infectious organisms
[9,10,11,12,13]. Indeed, some studies have reported the presence
of persistent bacteria on endoscopes despite cleaning and
disinfection procedures [14,15]. Interestingly, a viable strain of
B. subtilis was recently isolated from an endoscope washer-
disinfector after high level disinfection with chlorine dioxide
[16]. The authors showed that this isolate had developed cross-
resistance against other oxidising agents using a standard suspen-
sion test. Recently, we showed that this stable isolate was able to
produce a thick immersed biofilm with specific protruding
structures [17]. In this work, we have now investigated the
resistance of this strain in biofilm to peracetic acid (PAA), an
oxidizing agent commonly used in formulations used for
endoscope disinfection. In addition, we examined the ability of
the NDmedical strain to protect Staphylococcus aureus, a pathogen
responsible of a large number of hospital acquired infections [18],
from biocidal action in a mixed biofilm.
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Materials and Methods
Bacterial Strains and Growth Conditions
The bacterial strains used in this study are listed in Table 1. The
GFP-carrying Bacillus subtilis NDmedical strain was obtained by
transforming B. subtilis NDmedical to spectinomycin resistance with
chromosomal DNA of strain GM2812 [17], thus placing in the
amyE locus the gfp (mut2) gene under the control of the IPTG-
regulated Phyperspank promoter. Transformation was performed
according to standard procedures and the transformants were
selected on Luria-Bertani (LB, Sigma, France) plates supplemented
with spectinomycin at 100 mg/ml. Before each experiment,
bacteria were subcultured twice in Tryptone Soya Broth (TSB,
BioMe´rieux, France). When necessary, IPTG at a final concen-
tration of 200 mM was added to the medium to induce GFP
production, and antibiotics at the following concentrations:
spectinomycin, 100 mg/ml; erythromycin, 3 mg/ml.
Biofilms Architecture
Confocal Laser Scanning Microscopy (CLSM). Biofilms
were formed in polystyrene 96-well microtiter plates with a mclearH
base (Greiner Bio-one, France) enabling high-resolution fluores-
cence imaging as previously described [19]. For single species
biofilms, 250 ml of an overnight culture in TSB adjusted to an
OD600nm of 0.02 were added to the wells of the microtiter plate.
For mixed species biofilm, overnight cultures in TSB of S. aureus
AH478 mCherry and the B. subtilis GFP strains were adjusted to
an OD600nm of 0.02 in TSB and mixed at a ratio of 1:2. The
microtiter plate was then kept at 30uC for 90 min to enable
bacteria to attach to the bottom of the wells. After this adhesion
step, the wells were rinsed with TSB to eliminate non-adherent
bacteria and then refilled with 250 ml sterile TSB. The microtiter
plate was then incubated for 24 h at 30uC to allow biofilm
development. After development, biofilms were rinsed with
150 mM NaCl and series of xy images with a z-step of 1 mm
were then acquired to explore the three-dimensional structure of
the biofilms. Both single and mixed biofilms were scanned using an
excitation wavelength of 458 nm (argon laser, 25% intensity) and
543 nm (helium-neon laser, 50% intensity), with emission
wavelengths collected from 480 to 530 nm and from 580 to
700 nm respectively for GFP and mCherry fluorescence. Three-
dimensional projections of biofilm structures were reconstructed
using the Easy 3D function of the IMARIS 7.0 software (Bitplane,
Switzerland) directly from xyz images series.
Scanning Electronic Microscopy (SEM). For SEM obser-
vations, B. subtilis biofilms were prepared by immersing coupons in
the wells of a 24-well polystyrene plate containing bacterial
suspensions adjusted to an OD600nm of 0.02. After 90 min of
adhesion, coupons were rinsed and wells were refilled with 1 ml of
TSB. The plate was then incubated at 30uC for 24 h. After
development, biofilms were rinsed with 150 mM NaCl and
attached bacterial cells were fixed in a solution containing 2.5%
glutaraldehyde, 0.1 M sodium cacodylate (pH 7.4), 0.075%
ruthenium red and 0.015% Alcian blue for 20 h. Ruthenium
red and Alcian blue were added to the fixing solution because it
have been showed that their presence could promote the
visualization of extrapolymeric substances such as bofilm matrix
components [20,21]. Samples were then washed three times for
10 min with a solution containing 0.1 M sodium cacodylate,
0.075% ruthenium red and 0.015% Alcian blue before being
transferred into 50% ethanol. Samples were progressively dehy-
drated by passage through a graded series of ethanol solutions
from 50% to 100%. Finally, the samples were critical point
dehydrated (Emitech K850, UK) using carbon dioxide as the
transition fluid and coated with gold-palladium in an automatic
sputter coater (Polaron SC7640, UK). Scanning electron micros-
copy Quanta 650 FEG-SEM (FEI, Japan) was used to observe the
samples.
Congo red indicator assay on macrocolonies. The
morphology of macrocolonies formed by both B. subtilis strains
and their Congo Red binding properties were tested using
indicator agar plates. Experimentally, 5 ml of an overnight culture
in TSB were inoculated on TS agar (1.5%) containing 40 mg/ml
Congo Red (Sigma-Aldrich, France). Plates were then incubated
for 72 h at 30uC.
Determination of the sugar and protein contents of the
biofilmmatrix. The protein and sugar levels of the matrix of B.
subtilis 168 and NDmedical biofilms were determined after 24 h of
development in TSB. Biofilms were rinsed in distilled water and
recovered from the microtiter plate by scraping the bottom of the
wells with tips and aspirating and expelling the suspension at least
10 times. The suspensions were then vortexed during 30 seconds
before being centrifuged at 4000 g during 20 minutes. After, the
supernatants were transferred in sterile tubes and vortexed 30
seconds before being keeped at 20uC until biochemical assays were
performed. Protein contents were evaluated using the Bradford
assay [22] with bovine serum albumin as the standard. Sugar levels
were determined by using the phenol-sulfuric acid assay procedure
[23] with glucose as the standard. Each experiment was performed
in triplicate on three independent biofilm extractions.
Biocide Treatments
Biocide testing. After development, biofilms in the micro-
titer plates were rinsed and the wells refilled with 100 ml of TSB.
Then, 100 ml of peracetic acid (PAA) (32 wt. % in dilute acetic
acid (Sigma-Aldrich, France)) at 7000 ppm were then added in the
wells to obtain a final concentration of 3500 ppm. After 5 min of
contact, biocide solutions were gently removed and wells were
refilled with a quenching solution (3 g/L L-a-phosphatidyl cholin,
30 g/L Tween 80, 5 g/L sodium thiosulfate, 1 g/L L-histidine,
Table 1. Strains used in this study.
Strain Relevant genotype or description a Reference or construction
B. subtilis 168 trpC2 Bacillus Genetic Stock Center
B. subtilis 168 GFP amyE::Phyperspank-gfp (specR) [17]
B. subtilis NDmedical Freshly isolated from endoscope washer-disinfectors [16]
B. subtilis NDmedical GFP amyE::Phyperspank-gfp (specR) B. subtilis GM2812 [17] NDmedical
S. aureus AH478 Strain RN4220 with a plasmid harbouring a mCherry gene (eryR) [48]
aspec and ery stand for spectinomycin and erythromycin resistance markers respectively.
doi:10.1371/journal.pone.0044506.t001
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30 g/L saponine) and left for 5 min to stop biocide action. The
bottom of the wells was then scraped with tips and the suspension
aspirated and expelled many times to detach and recover survivor
cells from biofilms. The suspensions were then serially diluted in
150 mM NaCl and plated on Tryptone Soya Agar (TSA,
Biome´rieux, France) before being incubated at 30uC for 24–48 h.
To determine the sensitivity of B. subtilis NDmedical cells to PAA
following disruption of the biofilm, biofilms were rinsed with TSB
and cells were recovered by scraping the bottom of the wells with
tips and aspirating and expelling many times the suspension. The
recovered cells were mixed with 150 mM NaCl containing glass
beads and suspension vortexed for 30 s to separate cells and
extracellular matrix. The suspension was then washed after
centrifugation (7000 g, 10 min, 20uC) and adjusted to 108 CFU/
ml in 150 mM NaCl. In parallel, planktonic bacteria were
harvested from a 24 h culture in TSB at 30uC by centrifugation
(7000 g, 10 min, 20uC) followed vortexing with glass beads
(0.5 mm of diameter) for 30 s and then washed in 150 mM NaCl
before also adjusting to 108 CFU/mL. Peracetic acid activity was
then evaluated according to the standard European NF EN 1040
procedure [24] at a final concentration of 5 ppm with the adjusted
cell suspension. Survivors were counted after incubation by
comparing the number of colonies with those obtained when
biocide was replaced by distilled water. Each experiment was done
in triplicate.
In parallel, the susceptibility to peracetic acid at 5 ppm of
planktonic suspensions of B. subtilis 168, B. subtilis NDmedical and S.
aureus AH478 was evaluated. The resistance of S. aureus AH478
suspension in absence or presence of extracellular matrix extracted
from B. subtilis 168 or NDmedical biofilm was also determined. In
this aim, biofilm matrix extracts were directly added to S. aureus
AH478 suspension at a 1/10 (vol/vol) concentration before
disinfection step according to the NF EN 1040 standard pro-
cedure. Finally, we determined the susceptibility of mixed
suspensions of S. aureus with B. subtilis 168 or NDmedical strain to
evaluate to potential role of a soluble effector in the resistance of
the pathogen in mixed communities. In this end, S. aureus AH478
and B. subtilis 168 or NDmedical were grown together in TSB
overnight before peracetic acid treatment at 5 ppm using NF EN
1040 standard procedure.
Real-time visualization of PAA activity in biofilms. Time
lapse CLSM analysis of PAA action was performed in B. subtilis
biofilms as previously described [25]. This technique permits the
direct visualization of cell inactivation patterns in biofilm
structures during biocide action. The method is based on the
monitoring of fluorescence loss caused by the leak of an unbound
fluorophore outside the cells after disruption of the bacterial
membrane by antimicrobial agents. Experimentally, 24 h biofilms
in a microtiter plate were rinsed with TSB in order to eliminate
planktonic cells. The wells were then refilled with 100 ml of TSB
containing Chemchrome V6 (1:100 of commercial solution (AES
Chemunex, France)). Chemchrome V6 is an esterasic marker
which enter cells passively and is then cleaved by cytoplasmic
esterases, leading to the intracellular release of fluorescent residues
(green fluorescence). Microtiter plates were incubated in the dark
at 20uC for 1 h in order to reach fluorescence equilibrium.
Biofilms were then rinsed to eliminate excess Chemchrome V6
and refilled with 100 ml of TSB. The microtiter plate was then
mounted on the motorized stage of a Leica TCS SP2 AOBS
Confocal laser scanning microscope (LEICA Microsystems,
France) at the MIMA2 microscopy platform (http://voxel.jouy.
inra.fr/mima2). The CLSM control software was set to take
a series of time-lapse xyzt scans (2566256 pixels) at intervals of
15 s at five different depths in the biofilm. Biofilms were scanned
at 400 Hz using a 636oil objective with a 1.4 numerical aperture
with a 488 nm argon laser set at 10% of its maximal intensity.
These settings, which were shown to avoid photobleaching of the
sample by performing preliminary scans using distilled water
instead of biocides, were used in all time-lapse experiments.
Emitted V6 Chemchrome green fluorescence was recorded within
the range 500–600 nm. After the starting of the xyzt scan series,
100 ml of PAA at 7000 ppm were gently added to the wells just
after the completion of the first scan. Biofilms were then scanned
every 15 s at five different depths over 10 min, and fluorescence
loss within the structure was recorded. Three independent
experiments were performed for each strain.
Quantification of green fluorescence intensity from the time-
lapse (xyzt) CLSM image series was performed using confocal
software LCS Lite (Leica Microsystems, France). Intensity values
were then normalized by dividing the fluorescence intensity
recorded by the initial fluorescence intensity value at the same
location. Fluorescence intensity curves shown are the mean of
three experiments, each experiment constituting the average of
five horizontal sections along the depth of the biofilm.
Application of bacterial destruction models on
fluorescence intensity curves. GinaFiT, a freeware Add-inn
for MicrosoftH Excel developed by Geeraerd et al. [26] was used to
modelize inactivation kinetics. This tool enables testing of nine
different types of microbial survival models, and the choice of the
best fit depends on five statistical measures (i.e., sum of squared
errors, mean sum of squared errors and its root, R2, and adjusted
R2). During this study, the ‘‘log-linear + tail’’ inactivation model
was fitted on fluorescence intensity curves obtained from CLSM
image series during biocide treatment. The inactivation rate kmax
(min21) was extracted from the fitting.
Detection of spores. In order to check the presence of spores
in the biofilm after 24 h of development, cells were recovered from
the microtiter plates as described above and resuspended in
150 mM NaCl and boiled at 100uC for 10 min. Bacterial numbers
(cfu/ml) were determined before and after the heat treatment.
Statistical Analysis
One-way ANOVA was performed using Statgraphics v6.0
software (Manugistics, Rockville, USA). Significance was defined
as a P value associated with a Fisher test value lower than 0.05.
Results
Phenotypic Characterization of Biofilms Formed by
NDmedical and 168 Strains
Biofilms formed by a non-domesticated B. subtilis strain
(NDmedical) recently isolated from an endoscope washer-disinfector
and by the laboratory B. subtilis 168 strain were characterized.
First, the architecture of biofilms formed by both B. subtilis GFP
strains was observed after 24 h of development using CLSM as
presented in Fig. 1A. The images correspond to three-dimensional
reconstructions obtained from confocal stack images by the
IMARIS software, including virtual shadow projections on the
right. In accordance with previously published observations [17],
we found that the non-domesticated B. subtilis NDmedical strain
clearly developed a thicker biofilm with protruding structures in
comparison to strain 168 in these experimental conditions.
In order to visualize the extracellular material produced in
biofilms of both B. subtilis 168 and the NDmedical strains, SEM
observations were also performed. In both cases, the extracellular
material detected appeared to be composed of tangled thread-like
strands forming a complex network. However, this was clearly
much denser in the biofilm of the NDmedical strain as shown in
Resident Biofilms Protect Pathogen from Biocide
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Fig. 1B. It should be noted here that SEM observations required
several dehydration steps during sample preparation and therefore
the electron micrographs can not be considered as faithful
representations of fully hydrated biofilms. However, these results
clearly indicated the presence of larger amount of extracellular
substances in NDmedical strain biofilm in comparison to strain 168.
Since Congo Red is known to bind extracellular substances, it
has been widely used in previous works to compare the ability of
different strains to produce extracellular components in numerous
bacterial species including B. subtilis [27,28,29]. Macrocolonies of
both B. subtilis strains grown for 72 h on Congo Red indicator
plates are presented in Fig. 1C. We observed that NDmedical
produced highly wrinkled macrocolonies as compared to strain
168. In addition, the NDmedical strain stained red more intensively
on Congo Red indicator plates, suggesting a higher amount of
exopolymeric substances.
In line with this, biochemical quantification of the extracellular
matrix confirmed that NDmedical produced more abundantly
extracellular components than strain 168. Indeed, sugar and
protein contents of biofilm matrix reached respectively 33.561.4
and 26.761.0 mg/l for NDmedical strain whereas these values
attained only 13.160.8 and 8.760.3 mg/l for the strain 168.
B. subtilis NDmedical Biofilms Exhibit a Marked Resistance
to PAA
The resistance of biofilms formed by both B. subtilis strains
exposed to 3500 ppm of PAA for 5 min was then investigated.
These conditions represent the in-use PAA concentration and time
of exposure commonly used in hospitals for the disinfection
treatment of endoscopes. The results showed substantial resistance
of the B. subtilis NDmedical strain which exhibited only 3.8 log of
reduction while no survivor were detected on plates for strain 168,
corresponding to a reduction greater than 5.6 log (Table 2). Using
thermic treatment, we confirmed that NDmedical biofilm did not
contain any spores at 24 h of development showing that the
resistance observed was displayed by vegetative cells.
The resistance of the NDmedical biofilm was investigated further
by time-lapse CLSM microscopy allowing to visualize biocide
action in real-time within the biofilm structures of both B. subtilis
Figure 1. Architecture of B. subtilis communities. (A) Three-dimensional projection of B. subtilis 168 GFP and NDmedical GFP biofilms obtained
from xyz confocal images series using IMARIS software. Images present an aerial view of biofilm structure with the virtual shadow projection on the
right. Scale bar correspond to 50 mm. (B) SEM images of 24 h-biofilms. (C) Dye binding properties of B. subtilis macrocolonies grown for 72 h on
Congo red indicator plates.
doi:10.1371/journal.pone.0044506.g001
Table 2. Bactericidal activity of water and 0.35% PAA on
single and mixed species biofilms after 5 min of treatment.
log (CFU/well)
Strain Water PAA (0.35%)
Single species
biofilm
B. subtilis 168 7.660.2 –
B. subtilis
NDmedical
7.760.1 3.960.6
S.aureus AH478 9.360.1 –
Mixed species
biofilm
B. subtilis 168 7.560.5 –
S.aureus RN4220 8.260.4 –
B. subtilis
NDmedical
7.360.3 3.960.3
S.aureus RN4220 8.460.1 2.660.5
Data shown are mean of three experiments6 standard deviation. Samples from
which no survivor were recovered are represented by (2). Minimum detection
of 2 logs CFU/well.
doi:10.1371/journal.pone.0044506.t002
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strains. Figure 2A presents the dynamics of fluorescence loss
(membrane permeabilisation) within the biofilms during treatment
with 500 ppm of PAA. This concentration was chosen in order to
enable the visualization of biofilm damage in approximately
10 min. When biofilms were treated with distilled water as
a control, the loss of fluorescence observed was less than 1% (n= 4)
of the initial fluorescence after 10 min of treatment. The GinaFIT
‘‘log linear + tail’’ inactivation model [26] was applied to these
experimental data to extract the inactivation rate kmax and this
revealed satisfactory adjustment (R2.0.982). The results con-
firmed the greater resistance of the biofilm for strain NDmedical as
compared to the laboratory strain 168. While PAA treatment
resulted in an immediate and uniform loss of fluorescence of cells
in the biofilm for strain 168, the loss of fluorescence in the
NDmedical biofilm was slow and heterogeneous during disinfection
treatment. The extracted kmax inactivation rates showed a large
and significant difference between strain 168 and NDmedical (inset
in Fig. 2, P,0.05) with values of 14.0 and 0.4 respectively. Spatial
patterns of fluorescence loss in biofilms treated with 500 ppm PAA
are presented in Figure 2B. A homogeneous and sharp loss of
fluorescence was seen in the whole biofilm structure of strain 168
following the application of biocide. Conversely, PAA application
led to a non-homogenous loss of fluorescence within the biofilm
structure of the NDmedical strain. Indeed, with this strain, we
observed that spreading of PAA was difficult in some areas and
these remained fluorescent even after 10 min of treatment,
illustrating the high resistance and associated low inactivation
rate kmax displayed by this strain.
The resistance to PAA (5 ppm) of cells following removal and
washing from the biofilm of strain NDmedical was investigated and
compared to the resistance of the corresponding planktonic cells.
Reductions of 2.960.3 and 2.860.1 log (cfu/ml) were obtained
for planktonic cells and detached cells respectively i.e. no
significant difference (P.0.05). The disruption of the biofilm
and at least partial elimination of extracellular substances thus led
to the disappearance of the PAA resistance.
The NDmedical Strain Provides Protection to S. aureus
Against PAA in a Mixed Biofilm
The previous results showed that the NDmedical biofilm
exhibited marked resistance to PAA treatment and suggested that
the extracellular matrix likely plays an important role in this
resistance. We next investigated whether the NDmedical biofilm can
provide protection in a mixed biofilm to S. aureus, a pathogenic
strain present in medical environments and often incriminated in
nosocomial infections.
As shown on Fig. 3A, S. aureus alone produced flat and regular
biofilm with a thickness of 20–30 mm. When this single species
biofilm was exposed to 3500 ppm of PAA for 5 min, the small
numbers of survivors on plates corresponded to a more than
7.3 log of reduction compared to distilled water control (Table 2).
However, when growing in a mixed biofilm with B. subtilis
NDmedical, the same PAA treatment produced a 5.9 log reduction
of S. aureus suggesting that pathogenic strain acquired benefit from
strain association. Note that B. subtilis NDmedical resistance to PAA
was similar in both single and mixed biofilms with 3.8 and 3.4 log
reduction respectively. In contrast, mixed biofilm composed of the
lab strain B. subtilis 168 and S. aureus AH478 did not gain a higher
resistance to PAA compared to the single species biofilms.
Confocal observations showed that, in the presence of S. aureus
AH478, B. subtilis NDmedical was able to develop three-dimensional
structures similar to those observed in the single species biofilm of
this strain (Fig. 3 B). The S. aureus cells largely covered the surface
of the bottom of the wells not occupied by the B. subtilis strain
although some cells were trapped in the protruding structures
formed by the NDmedical strain.
Interestingly, when B. subtilis NDmedical biofilm matrix extract
was added to a S. aureus AH478 suspension before peracetic
treatment at 5 ppm, we enumerated survivors on Petri dishes with
a reduction of 3.660.3 log whereas no survivor (log reduction
.4.1 log) was observed when matrix extract from B. subtilis 168
biofilm was added to S. aureus AH478 suspension in the same
conditions. When examining the resistance of mixed overnight
culture of S. aureus AH478 with each B. subtilis strains to peracetic
acid, we did not observed, in both cases, a significant better
resistance of the pathogen compared to single S. aureus culture
(P.0.05).
Together, these results underline that a direct interaction of
NDmedical biofilm matrix components with peracetic acid likely
plays a key role in the better resistance of S. aureus AH478 observed
in mixed biofilm.
Discussion
In a previous study, Martin et al. [16] isolated a strain of B.
subtilis (called NDmedical in this study) from an endoscope washer-
disinfector and showed that this strain developed a high resistance
against various oxidising agents using a standard suspension test.
On the basis of SEM observations, they suggested that this
resistance could be due to a higher production of matrix in
comparison with sensitive strains. Recently, we showed that this
stable isolate produces a very thick biofilm with specific protruding
and elevated structures in comparison to other B. subtilis strains
[17], and this was confirmed in our present observations. As
biofilm formation is frequently associated with increased resistance
to sanitizing treatments and antibiotic therapies [30,31,32], the
enhanced biofilm-forming ability of strain NDmedical can thus
represent a strategy to survive despite the regular exposure to
biocide treatments. In line with this, Shemesh et al. [4] showed that
sublethal doses of chlorine actually stimulated biofilm formation
by B. subtilis, reflecting an apparent defensive response against
biocide action. In addition, it has been shown in P. aeruginosa that
hyper-biofilm forming variants appear due to self-generated
diversity occuring in the biofilm, and this was correlated with
higher resistance of the whole community to hydrogen peroxide
[33]. Our present results showed a very high resistance of the
NDmedical biofilm to PAA, an oxidizing agent commonly used in
formulations used in endoscope disinfection; highlighting that
biofilm formation could indeed enable this strain to persist despite
drastic disinfection treatments applied during endoscope de-
contamination. Some evidence appears to suggest that this high
resistance could be mainly related to an increased production of
extracellular matrix in agreement with the previous observations
made by Martin et al. [16] with planktonic cells. First, the
disruption of the three-dimensional biofilm structure and washing
of cells led to the restoration of a PAA sensitivity similar to that
observed for planktonic cells. In addition, SEM observations and
Congo red assays showed that the NDmedical strain produced
a denser and more abundant extracellular substances when
compared with strain 168, which was much more sensitive to
PAA. Finally, biochemical assay showed that sugars and proteins
contents in NDmedical biofilm were respectively 2.6 and 3.1 times
higher than in the biofilm formed by the strain 168. These results
highlight the primordial role of the three-dimensional structure of
the biofilm of NDmedical strain and the abundant matrix that could
play a protective role through the interaction with and the
quenching of PAA reducing thus its penetration into the biofilm.
Previous studies reported that penetration limitations encountered
Resident Biofilms Protect Pathogen from Biocide
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Figure 2. Real-time visualization of PAA (0.05%) activity in B. subtilis biofilms. (A) Quantification of Chemchrome V6 fluorescence intensity
in B. subtilis 168 (white squares) and NDmedical (black squares) biofilms during PAA treatment at 500 ppm. Values shown corresponds to the average
of the fluorescence at five depths with standard deviation in the biofilm for a representative experiment. Inactivation rate kmax was obtained after
fitting GinaFIT ‘‘log linear + tail’’ inactivation model on experimental data. The means of three experiments6 standard deviation are presented in the
inset. (B) Visualization of Chemchrome V6 fluorescence loss (membrane permeabilisation) in B. subtilis 168 and NDmedical biofilms at 0. 15 and 30
secondes and 0. 5 and 10 minutes respectively during PAA treatment (0.05%). Each image corresponds to the superimposition of a green
fluorescence image of a representative experiment on a greyscale image of initial fluorescence at the same location. Scale bars correspond to 20 mm.
doi:10.1371/journal.pone.0044506.g002
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by chlorine, another oxidising agent, in biofilms of different species
can explain at least partly the reduced activity of this molecule
probably due to interactions with biofilm constituents [34,35,36].
Kinetic profiles and spatial patterns of fluorescence loss (cell
membrane permeabilization) obtained using CLSM time lapse
visualization of PAA action in the NDmedical biofilm (Fig. 2) were
consistent with these observations. Indeed, the progressive action
of PAA in the heterogeneous structure of biofilm, with cells in
some internal areas remaining fluorescent even after 10 min of
treatment illustrate the limited action of the biocide in these areas.
In line with these observations, we can hypothesize that the
presence of dense matrix domains in the NDmedical biofilm may
constitute the principal mechanism involved in resistance to PAA.
Whether this phenotype is related to one or several matrix
components needs to be addressed. In particular, the involvement
of molecular constituents already known to participate to the
matrix composition of B. subtilis such as epsA-O operon products
[37,38] or TasA amyloid fibers [29,39] for the most clearly
identified, should be investigated. The nucleotide sequences of the
epsA-O and yqxM/sipW/tasA operons, including their promoter
regions, were identical in both the NDmedical and 168 strains (data
not shown). In addition, construction of transcriptional fusion
genes with a fluorescent reporter associated with flow-cytometry
showed no significant difference between expression of the epsA-O
operon in NDmedical and 168 strains, whereas expression of the
yqxM/sipW/tasA operon was significantly higher in biofilms of the
reference strain as compared to the NDmedical strain (P,0.05,
data not shown). Taken together, these data indicated that the
resistance observed of the strain NDmedical was likely not due to
modification of any of these major elements involved in the B.
subtilis matrix composition, but rather to different genes that
remain to be identified.
We also investigated whether S. aureus can be protected from
disinfection in a mixed biofilm with B. subtilis NDmedical strain. S.
aureus is a bacterial pathogen commonly found in hospitals and
responsible for a large number of infections [18,40], and numerous
studies have reported the presence of S. aureus on endoscopes even
after disinfection procedures [15,41]. Our results demonstrated
that more than 7.3 log of reduction (no survivor enumerated) were
obtained for S. aureus single species biofilm after PAA treatment at
3500 ppm whereas we found only 5.9 log of reduction when
growing in mixed biofilm with NDmedical strain (Table 2). These
results showed a protective effect of the presence of B. subtilis
NDmedical strain to S. aureus against PAA activity. Confocal images
revealed that some S. aureus cells were entrapped in the protruding
structures formed by the NDmedical strain and thus probably
benefited from the protective matrix of the B. subtilis strain.
Supporting this hypothesis,addition of B. subtilis NDmedical biofilm
matrix extract to a S. aureus AH478 planktonic suspension led to
a better resistance of the pathogen to peracetic acid. Moreover,
since the concomitant growth of S. aureus with the NDmedical strain
in suspension had no effect on the resistance of S. aureus, it is likely
that the higher survival of S. aureus in mixed biofilm was mainly
due to the quenching of the oxidizing agent by the abundant
extracellular matrix produced by the B. subtilis NDmedical strain,
rather than a soluble effector which could trigger the pathogen
resistance. Different works already reported that species associa-
tions in mixed biofilms can result in a higher resistance to
disinfection compared to single species biofilms [42,43,44,45,46]
and that some species can protect another throughout interspecies
spatial associations. Leriche et al. [47] reported for instance that
Staphylococcus sciuri was protected in a mixed biofilm against
a chlorinated solution by microcolonies formed by Kocuria sp.,
a more resistant strain. As it is clear that microbial communities
present in medical or industrial areas are complex multispecies
associations rather than controlled single species model, these
findings highlight the importance to challenge biocides on
representative multispecies biofilm models of the environment
considered. In this study, peracetic acid alone was tested but it
should be highlighted that further studies are required to
understand the impact on PAA-containing formulations. Product
formulations can vary considerably on their activity against
biofilms due to presence of other chemicals, such as chelating
agents and detergents. These can help detach and disaggregate the
biofilms, thus facilitating biocidal activity.
In conclusion, this work points out that the selection pressure
maintained in healthcare environments by regular disinfection
treatments can lead to the emergence of strains with hyper-
resistance phenotypes. This is related to the great ability of
bacteria to adapt to their environments by developing efficient
survival strategies such as biofilm formation. Particular attention
should thus be paid to the choice of strains which are
representative of the reality of medical areas in disinfectant
testing. In addition, the necessity to consider the resident microbial
ecosystem (including non-pathogenic but resistant strains as B.
subtilis NDmedical) instead of pathogen alone is emphasized since
the persistence of a strain can be related not directly to its intrinsic
resistance but also to the interactions with other species present in
Figure 3. Architecture of S. aureus AH478 mCherry biofilm and B. subtilis NDmedical GFP/S.aureus AH478 mCherry mixed biofilm. (A) 3D
reconstruction of S.aureus AH478 mCherry biofilms.(B) 3D reconstruction and section at higher magnification of mixed species biofilm of B. subtilis
NDmedical GFP (green)/S.aureus AH478 mCherry (red). Scale bars correspond to 20 mm.
doi:10.1371/journal.pone.0044506.g003
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the environment. Future works will focus on the understanding of
the adaptation mechanisms leading to an increased resistance of
bacteria to biocides in these environments.
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